Investors Eye Corcept Therapeutics as Clinical Breakthroughs Signal a Major Growth Phase
Corcept Therapeutics has long occupied a unique niche in the biopharmaceutical sector by focusing exclusively on the modulation of cortisol. While the
by 
Josh Weiner
Josh Weiner